celebrating

20 years

of transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care

5 Ways We’re Innovating the Digital Experience for Claims Professionals

Claims professionals have long been the frontline of claims management – this has not changed. What has changed is just about everything else.
Read More

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Read More

2021 Industry Insights Survey Report

We surveyed 600+ workers’ comp professionals on the biggest industry disruptors and priorities.
Read More

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

FDA Reexamines Discontinued Drug for New Pain Applications

Orphengesic Forte has received a decision date of August 14, 2019.

Jun 2019

Shifting Gears in Patient Transportation with Rideshare

How services like Lyft and Uber can amplify injured worker transportation programs to improve claims outcomes.

Jun 2019

The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

Jun 2019


First Public Hearing for Cannabidiol (CBD) Products

Though most forms of marijuana are highly regulated, CBD products are readily available across the country. What does this mean for healthcare?

Jun 2019

FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

Jun 2019

FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

May 2019

2019 Workers’ Comp Industry Insights Survey

Healthesystems partnered with Risk & Insurance magazine to survey 500+ work comp professionals on their top challenges, trends, successes, and more.

May 2019

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

May 2019

Growing Trend: Expanding Cancer Coverage for Firefighters

Florida enacted a law to cover 21 different cancers, while other states like Montana, Maryland, and Virginia have recently passed similar laws.

May 2019

National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

May 2019

FDA Tightens Restrictions for Transmucosal Fentanyl Products

New changes to REMS safety programs will require stronger treatment documentation and oversight.

Apr 2019

Patient Engagement is Personal: How to Help Injured Workers Help Themselves

Patient engagement can lead to better health outcomes, but not all engagement strategies are equally effective.

Apr 2019

The Impact of the Changing Workforce

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

Apr 2019

Marijuana Continues to Take Major Steps Forward

Congress may soon clear federal restrictions to processing marijuana transactions, while the FDA asks for feedback on handling marijuana products.

Apr 2019

Oklahoma Reaches $270 Million Settlement with Opioid Manufacturer

Various state and local governments have sued drug developers for the harms of the opioid epidemic, and this could be the first of many settlements.

Apr 2019

Tanezumab Trials Yield Positive Results for Pain Management

Phase 3 clinical trials for this non-opioid drug demonstrate significant reductions in pain for osteoarthritis and chronic low-back pain.

Mar 2019

Opioid Imbalance: Risk Disparities Among Diverse Patient Populations

Demographic factors such as gender, ethnicity, socioeconomic status, age, and location can impact opioid risks.

Mar 2019

Tackling Topicals: Clinicians Takes Notice

Despite having little clinical impact, topical creams continue to be utilized widely in workers’ comp.

Mar 2019

The Drug Price Debate

Federal lawmakers and administrative agencies continue to investigate how to best lower ever-increasing drug prices.

Mar 2019

FDA Establishes Guidance for Brain-Computer Interface Technologies

Can special implants in the brain override paralysis? The FDA believes one day they could.

Mar 2019

FDA Nudges Developers to Create Over-the-Counter Naloxone

The FDA created special drug labels to clear a development hurdle and encourage manufacturers.

Feb 2019

Marijuana – What to Expect in 2019 and Beyond

Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.

Feb 2019

Troubling Trends for Benzodiazepines

Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.

Feb 2019

PTSD Coverage: More States Draft Legislation

Kentucky, Connecticut, Idaho, and West Virginia proposed bills to make PTSD compensable for first responders.

Feb 2019


Opioid Marketing Tied to Higher Prescribing and Overdose

A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.

Feb 2019

FDA Approves Two New Strengths of Apadaz

The opioid prodrug for acute pain will soon be available in both a stronger and weaker dose.

Jan 2019

What’s Ahead for 2019 Workers’ Comp Regulations

As 2018’s legislative trends continue to spill into 2019, what big initiatives might impact workers’ comp this year?

Jan 2019

JAMA Examines Association of Early Physical Therapy with Long-Term Opioid Use

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

Jan 2019

The Legality of Self-Referrals

Can doctors in certain states refer patients to pharmacies which they partially own?

Jan 2019

The Buzz Behind Digital Therapeutics

Will doctors one day prescribe apps meant to drive behavior changes instead of drugs?

Jan 2019

1 2 3 4 5 9 10 11 12 13 14
lockenvelopephone-handsetmenuarrow-rightcross-circle